| 非清髓性异基因造血干细胞移植的创新与展望 |
| |
| 引用本文： | 陈学良. 非清髓性异基因造血干细胞移植的创新与展望[J]. 肿瘤学杂志, 2004, 10(6): 375-377 |
| |
| 作者姓名： | 陈学良 |
| |
| 作者单位： | 山东大学齐鲁医院肿瘤中心,山东,济南,250012 |
| |
| 摘 要： | 非清髓性异基因造血干细胞移植(NST)是在传统异基因造血干细胞移植的基础上发展起来的新移植领域,它减轻了预处理强度并加强了移植前后的免疫处理.因其并发症轻、危险性小而有广泛的应用前景,也有许多未知领域有待继续探讨.
|
| 关 键 词： | 造血干细胞移植 非清髓性预处理 述评 |
| 文章编号： | 1671-170X(2004)06-0375-03 |
| 修稿时间： | 2004-10-12 |
Innovation and Prospect of Non-myeloablative Allogeneic Stem Cell Transplantation |
| |
| CHEN Xue-liang. Innovation and Prospect of Non-myeloablative Allogeneic Stem Cell Transplantation[J]. Journal of Chinese Oncology, 2004, 10(6): 375-377 |
| |
| Authors: | CHEN Xue-liang |
| |
| Abstract: | Non-myeloablative allogeneic stem cell transplantation (NST) is a new field that based on traditional allogenic stem cell transplantation (Allo-SCT). It lessens the dose of pretreatment and strengthens the immune therapy before and after transplantation. Because of less complications and low harm, NST has a broad foreground for application. However, there are also many fields unknown in NST that need further research. |
| |
| Keywords: | stem cell transplantation non-myeloablative pretreatment review |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
